1
|
Fucci A, Giacobbe S, Guerriero I, Suzumoto Y, D'Andrea EL, Scrima M, Nolli ML, Iervolino A, Chiuchiolo LA, Salvatore E, Renzulli R, La Peccerella L, Marra G, Liuzzi M, Santoro D, Zulli E, Gentile R, Clemente G, Capasso G. The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients. Kidney Blood Press Res 2022; 47:467-474. [PMID: 35318291 PMCID: PMC9148885 DOI: 10.1159/000524034] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 03/08/2022] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION Since the pandemic of Coronavirus Disease 2019 (COVID-19) started from December 2019, remarkable numbers of infections and deaths associated with COVID-19 have been recorded worldwide. End-Stage Renal Disease (ESRD) patients on dialysis are particularly at high risk of infections due to impairments in the innate and adaptive immune system. Vaccination on dialysis patients (DP) still remains challenging, because of the variable response and low seroconversion rate compared with healthy controls (HC). Therefore, it is urgently necessary to establish a different vaccination strategy for DP, in terms of dose and administration time. METHODS Here, we report an observational prospective cohort study in which the immunogenic efficacies of SARS-CoV-2 vaccine BNT162b2 on DP and HC were evaluated by absolute quantification of IgG levels in the blood. RESULTS DP showed a delayed seroconversion after two vaccine doses, with a low absolute IgG levels compared to HC. While healthy populations reached complete seroconversion within 10 days from the administration of second dose, only 76% of DP were seropositive. After booster dose, DP strongly improved seroconversion rate as well as antibody levels, reaching 97% seropositivity and 50 times enhancement on antibody levels. DISCUSSION/CONCLUSION These results prompt to suggest an additional vaccine dose in DP, reducing the interval of time from the second dose. Since few data are available on immune response in DP overtime after three vaccine doses currently, our study is among the first reports demonstrating the improved seropositivity and IgG levels in DP after booster vaccine dose.
Collapse
Affiliation(s)
- Alessandra Fucci
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
| | - Simona Giacobbe
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
| | - Ilaria Guerriero
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
- *Ilaria Guerriero,
| | - Yoko Suzumoto
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
- **Yoko Suzumoto,
| | | | - Marianna Scrima
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
| | - Maria Luisa Nolli
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
| | - Anna Iervolino
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
- Department of Translational Medical Science, University of Campania “Luigi Vanvitelli,”, Naples, Italy
| | | | | | | | | | | | - Marco Liuzzi
- Haemodialysis Center Sanniomedica Srl, Telese Terme, Italy
| | | | - Enrico Zulli
- Haemodialysis Center Alta Irpinia Srl, Calitri, Italy
| | | | - Gennaro Clemente
- IRPPS, Institute for Research on Population and Social Policies, CNR, Fisciano, Italy
| | - Giovambattista Capasso
- Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, Italy
- Department of Translational Medical Science, University of Campania “Luigi Vanvitelli,”, Naples, Italy
| |
Collapse
|
2
|
Cianci R, Martina P, Cianci M, Lavini R, Stivali G, Di Donato D, Polidori L, Lai S, Renzulli R, Gigante A, Barbano B. Ischemic nephropathy: proteinuria and renal resistance index could suggest if revascularization is recommended. Ren Fail 2011; 32:1167-71. [PMID: 20954976 DOI: 10.3109/0886022x.2010.516856] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The aim of endovascular therapy in renal artery stenosis (RAS) is to preserve renal function and have a better hypertension control. The purpose of our study was to determine which biochemical and instrumental parameters could predict a better renal outcome in patients with RAS treated with percutaneous transluminal angioplasty and stenting (RPTAS). METHODS We performed an observational study based on 40 patients with RAS who met the following criteria before revascularization: urinary protein excretion of over 250 mg/24 h, normal renal function, and/or mild-moderate renal insufficiency (I, II, and III levels of classification of chronic kidney disease, K-DOQI). RESULTS Assessment at 12 months after RPTAS showed in 20 patients (Group A) that proteinuria serum creatinine (Scr) and creatinine clearance (CrCl) significantly worsened from the baseline; whereas in 20 patients (Group B) proteinuria remained unchanged and the renal function improved after the procedure. CONCLUSIONS In our study, the decline of renal function after RPTAS is associated with an elevated renal resistance index (RI) in both kidneys (0.83 ± 0.2) and preexisting proteinuria.
Collapse
Affiliation(s)
- Rosario Cianci
- Department of Nephrology, Sapienza University of Rome, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Cianci R, Stivali G, Gigante A, Di Donato D, Polidori L, Clemenzia G, Borghesi F, Renzulli R, Martina P, Gasperini ML, Barbano B. Primary stenting for renal fibromuscular-dysplastic stenosis: a case report. Eur Rev Med Pharmacol Sci 2009; 13:317-319. [PMID: 19694348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic vascular disease that has been reported in renal and internal carotid arteries and in almost every arterial bed, primarily affecting young to middle-aged people, mainly female individuals. These patients may be asymptomatic or may present with hypertension. A 29 year-old hypertensive woman was referred for a renal color Doppler ultrasound (CDU) scan because of a suspicion of renovascular hypertension and we revealed the presence of three separate stenosis on the right renal artery. Digital selective angiography (DSA) and percutaneous transluminal angioplasty (PTA) were performed but an incomplete dilation of the vessel was obtained. Because of the suboptimal result, it was decided to stent the lesions during two different procedures. Percutaneous transluminal renal angioplasty is the primary treatment of renal FMD, but should not be excluded primary stent implantation as an alternative technique to surgical revascularization.
Collapse
Affiliation(s)
- R Cianci
- Department of Nephrology, University "La Sapienza", Rome, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Gigante A, Giannakakis K, Visentini M, Fiorilli M, Barbano B, Renzulli R, Borghesi F, Cianci R. A simultaneous occurrence of Tolosa-Hunt syndrome and fibrillary glomerulonephritis: a case report. J Clin Pathol 2009; 62:190-1. [PMID: 19181638 DOI: 10.1136/jcp.2008.061648] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Fibrillary glomerulonephritis (FibGN) is a rare cause of progressive renal dysfunction, often leading to dialysis within a few years. A 60-year-old woman presented with a 2 month history of right-sided retro-orbital pain and recent diplopia. Laboratory testing revealed an altered renal function with increased serum creatinine and mild proteinuria. MRI of the brain revealed the presence of a soft tissue mass on the right cavernous sinus compatible with the diagnosis of Tolosa-Hunt syndrome (THS). Renal biopsy showed a pattern compatible with fibrillary glomerulonephritis. For this reason steroid therapy was initiated at a dose of 1 mg/kg/day and adjusted according to the clinical course. Neurological symptoms regressed shortly after the beginning of therapy and renal function and proteinuria remained stable for the 3 years following the withdrawal of steroid therapy. Percutaneous renal biopsy was again performed and confirmed the previous diagnosis of FibGN in association with other glomerular-lesion-like mesangial widening, thickening of capillary walls and severe arterio-arteriolosclerosis. This case report describes what is believed to first report of the association of FibGN and THS, which both responded to steroid therapy.
Collapse
Affiliation(s)
- A Gigante
- Department of Nephrology, University La Sapienza, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Cianci R, Gigante A, Polidori L, Di Donato D, Martina P, Barbano B, Renzulli R, Zaccaria A, Fuiano G. In-Stent Restenosis of the Renal Artery in a Single Kidney Patient: The Role of ACEI in the Therapeutic Choice. Angiology 2008; 60:496-503. [DOI: 10.1177/0003319708322172] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Renal artery stenosis (RAS) caused by atherosclerotic changes of the renal arteries has become a concern as a cause of end-stage renal failure. Percutaneous balloon angioplasty with or without endovascular stenting is an increasingly accepted procedure at the expense of classical approaches such as aortorenal bypass and other types of surgery. Renal percutaneous transluminal angioplasty and stenting (RPTAS) represent the first therapeutic choice; however, there is doubt regarding the satisfactory long-term outcome for primary RPTAS. Currently, there is no clear evidence whether or not RPTAS prevents further progressive renal function decline because comparisons between interventional randomized studies and medical therapy are still lacking. Despite the fact that the use of angiotensin-converting enzyme inhibitors (ACEIs) may be a potential cause of acute renal failure, clinical data suggest that ACEI therapy is associated with better survival in patient with RAS. In our case, the use of ACEIs has been fundamental for the indirect evaluation of restenosis degree and RPTAS.
Collapse
Affiliation(s)
- Rosario Cianci
- Department of Nephrology, University of Rome “La Sapienza,”, Italy
| | | | - Lelio Polidori
- Department of Nephrology, University of Rome “La Sapienza,”, Italy
| | | | - Paola Martina
- Department of Nephrology, University of Rome “La Sapienza,”, Italy
| | - Biagio Barbano
- Department of Nephrology, University of Rome “La Sapienza,”, Italy
| | - Roberta Renzulli
- Department of Nephrology, University of Rome “La Sapienza,”, Italy
| | - Alvaro Zaccaria
- Vascular Surgery, S. Pietro Fatebenefratelli Hospital Rome, Italy
| | | |
Collapse
|
6
|
Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E, Vijayadamodar G, Pochart P, Machineni H, Welsh M, Kong Y, Zerhusen B, Malcolm R, Varrone Z, Collis A, Minto M, Burgess S, McDaniel L, Stimpson E, Spriggs F, Williams J, Neurath K, Ioime N, Agee M, Voss E, Furtak K, Renzulli R, Aanensen N, Carrolla S, Bickelhaupt E, Lazovatsky Y, DaSilva A, Zhong J, Stanyon CA, Finley RL, White KP, Braverman M, Jarvie T, Gold S, Leach M, Knight J, Shimkets RA, McKenna MP, Chant J, Rothberg JM. A protein interaction map of Drosophila melanogaster. Science 2003; 302:1727-36. [PMID: 14605208 DOI: 10.1126/science.1090289] [Citation(s) in RCA: 1581] [Impact Index Per Article: 75.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Drosophila melanogaster is a proven model system for many aspects of human biology. Here we present a two-hybrid-based protein-interaction map of the fly proteome. A total of 10,623 predicted transcripts were isolated and screened against standard and normalized complementary DNA libraries to produce a draft map of 7048 proteins and 20,405 interactions. A computational method of rating two-hybrid interaction confidence was developed to refine this draft map to a higher confidence map of 4679 proteins and 4780 interactions. Statistical modeling of the network showed two levels of organization: a short-range organization, presumably corresponding to multiprotein complexes, and a more global organization, presumably corresponding to intercomplex connections. The network recapitulated known pathways, extended pathways, and uncovered previously unknown pathway components. This map serves as a starting point for a systems biology modeling of multicellular organisms, including humans.
Collapse
Affiliation(s)
- L Giot
- CuraGen Corporation, 555 Long Wharf Drive, New Haven, CT 06511, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|